Σύνολο αποτελεσμάτων: 94, εμφανίζονται 41 - 50
Αποτελέσματα ανά σελίδα:  10  25  50  100
Ταξινόμηση ανά: Ημερομηνία · Επισκέψεις · Τίτλο
42 Inflammatory bowel disease related cancer
K.H. Katsanos,, E.V. Tsianos,
43 Inflammatory bowel disease: recent advances on genetics and innate immunity
Karantanos, Theodoros Gazouli, Maria,
The chronic inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis, arerecognized as important causes of gastrointestinal disease in children and adults. Insight intoIBD is advancin...
44 Insights into the pathogenesis of NAFLD: The role of metabolic and pro-inflammatory mediators.
E. Xirouchakis Penelopi Manousou Lemonia Tsartsali S. Georgopoulos A.K. Burroughs,
Non alcoholic fatty liver disease (NAFLD) is a part of the metabolic syndrome which also comprises obesity, dyslipidaemia, type 2 diabetes mellitus and hypertension. The importance of NAFLD is due to ...
45 Insulin-like growth factor system and inflammatory bowel disease
Katsanos K., Tsianos E.V.,,
SUMMARY Few reports concerning the levels and the importance of insulin-like growth factors (IGFs) and IGF binding proteins (IGFBPs) in the serum of patients with inflammatory bowel disease (IBD) have...
46 Interferon-based combination treatment for chronic hepatitis C in the era of direct acting antivirals
Alexopoulou, Alexandra; 2nd Department of Medicine, Medical School, University of Athens, Hippokrati...
The development of protease inhibitors (PIs) such as telaprevir and boceprevir constitutes a milestone in chronic hepatitis C antiviral treatment since it has achieved sustained virological response (...
47 Intestinal barrier dysfunction in obstructive jaundice: current concepts in pathophysiology and potential therapies
S.F. Assimakopoulos C.E. Vagianos C.E. Vagianos Vassiliki N. Nikolopoulou Vassiliki N. Nikolopoulou,
Patients with obstructive jaundice, especially when exposed to the additional stress of an invasive diagnostic or therapeutic procedure, are prone to septic complications and renal dysfunction contrib...
48 Intraperitoneal chemotherapy for prevention and treatment of peritoneal carcinomatosis from colorectal origin
J. Romanos, A.J. Witkamp, D.D. Tsiftsis, E. de Bree,, F.A.N. Zoetmulder,,
SUMMARY The peritoneal surface remains an important failure site for patients with colorectal cancer. Peritoneal metastases of colorectal cancer are at present considered equal to distant metastatic d...
49 Is primary biliary cirrhosis a risk factor for hepatic and extrahepatic malignancies?
Melanie Deutsch,
Primary biliary cirrhosis (PBC) represents a classical cause of liver cirrhosis but clear data about the true risk of the development of hepatocellular carcinoma (HCC) are still lacking.Data are based...
50 Liver Diseases Specific to Pregnancy
E. Cholongitas A. K Burroughs,
During pregnancy, there are some changes in the liver that occur physiologically, such as alternations in blood flow and hepatic cholesterol synthesis and secretion. However, liver diseases specific t...